SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: OldHack who wrote (649)1/7/1998 9:33:00 PM
From: Sergio H  Respond to of 1476
 
Good evening OH. In my opinion, there is no set answer to your question. It would depend on the potential market for the drug and the distribution agreement between the two companies.

Sergio



To: OldHack who wrote (649)1/7/1998 11:47:00 PM
From: Amigo Mike  Respond to of 1476
 
Hi OH,

Long time no see. Your question is a toughie. My answer would basically be that it depends on several factors. Market cap of each .... market potential ..... and so on. Another factor is the structure of the deal between the two companies.

OH ..... you have such companies in mind ?????? Be glad to take a peek =)

Mike


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News